These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

575 related items for PubMed ID: 10539815

  • 1. Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: results from the studies of left ventricular dysfunction (SOLVD).
    Knight EL, Glynn RJ, McIntyre KM, Mogun H, Avorn J.
    Am Heart J; 1999 Nov; 138(5 Pt 1):849-55. PubMed ID: 10539815
    [Abstract] [Full Text] [Related]

  • 2. ACE-inhibitor therapy at relatively high doses and risk of renal worsening in chronic heart failure.
    De Vecchis R, Di Biase G, Ariano C, Cioppa C, Giasi A, Ciccarelli A, Pucciarelli A, Cantatrione S.
    Arq Bras Cardiol; 2011 Dec; 97(6):507-16. PubMed ID: 22001954
    [Abstract] [Full Text] [Related]

  • 3. Baseline quality of life as a predictor of mortality and hospitalization in 5,025 patients with congestive heart failure. SOLVD Investigations. Studies of Left Ventricular Dysfunction Investigators.
    Konstam V, Salem D, Pouleur H, Kostis J, Gorkin L, Shumaker S, Mottard I, Woods P, Konstam MA, Yusuf S.
    Am J Cardiol; 1996 Oct 15; 78(8):890-5. PubMed ID: 8888661
    [Abstract] [Full Text] [Related]

  • 4. Trends in Kidney Function Outcomes Following RAAS Inhibition in Patients With Heart Failure With Reduced Ejection Fraction.
    McCallum W, Tighiouart H, Ku E, Salem D, Sarnak MJ.
    Am J Kidney Dis; 2020 Jan 15; 75(1):21-29. PubMed ID: 31303349
    [Abstract] [Full Text] [Related]

  • 5. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R, Ciccarelli A, Ariano C, Cioppa C, Giasi A, Pucciarelli A, Cantatrione S.
    Minerva Cardioangiol; 2011 Dec 15; 59(6):543-54. PubMed ID: 21330961
    [Abstract] [Full Text] [Related]

  • 6. Use of angiotensin-converting enzyme inhibitors in patients with heart failure and renal insufficiency: how concerned should we be by the rise in serum creatinine?
    Ahmed A.
    J Am Geriatr Soc; 2002 Jul 15; 50(7):1297-300. PubMed ID: 12133029
    [Abstract] [Full Text] [Related]

  • 7. The relevance of subgroup-specific treatment effects: the Studies Of Left Ventricular Dysfunction (SOLVD) revisited.
    Parker AB, Yusuf S, Naylor CD.
    Am Heart J; 2002 Dec 15; 144(6):941-7. PubMed ID: 12486418
    [Abstract] [Full Text] [Related]

  • 8. Prognostic importance of early worsening renal function after initiation of angiotensin-converting enzyme inhibitor therapy in patients with cardiac dysfunction.
    Testani JM, Kimmel SE, Dries DL, Coca SG.
    Circ Heart Fail; 2011 Nov 15; 4(6):685-91. PubMed ID: 21903907
    [Abstract] [Full Text] [Related]

  • 9. Beta-adrenergic blocking agent use and mortality in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a post hoc analysis of the Studies of Left Ventricular Dysfunction.
    Exner DV, Dries DL, Waclawiw MA, Shelton B, Domanski MJ.
    J Am Coll Cardiol; 1999 Mar 15; 33(4):916-23. PubMed ID: 10091816
    [Abstract] [Full Text] [Related]

  • 10. How prevalent is hyperkalemia and renal dysfunction during treatment with spironolactone in patients with congestive heart failure?
    Svensson M, Gustafsson F, Galatius S, Hildebrandt PR, Atar D.
    J Card Fail; 2004 Aug 15; 10(4):297-303. PubMed ID: 15309695
    [Abstract] [Full Text] [Related]

  • 11. Enalapril reduces the incidence of diabetes in patients with chronic heart failure: insight from the Studies Of Left Ventricular Dysfunction (SOLVD).
    Vermes E, Ducharme A, Bourassa MG, Lessard M, White M, Tardif JC, Studies Of Left Ventricular Dysfunction.
    Circulation; 2003 Mar 11; 107(9):1291-6. PubMed ID: 12628950
    [Abstract] [Full Text] [Related]

  • 12. The effect of enalapril on mortal and morbid events in patients with hypertension and left ventricular dysfunction.
    Kostis JB.
    Am J Hypertens; 1995 Sep 11; 8(9):909-14. PubMed ID: 8541006
    [Abstract] [Full Text] [Related]

  • 13. Interaction between aspirin and angiotensin-converting enzyme inhibitors: should they be used together in older adults with heart failure?
    Ahmed A.
    J Am Geriatr Soc; 2002 Jul 11; 50(7):1293-6. PubMed ID: 12133028
    [Abstract] [Full Text] [Related]

  • 14. Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction.
    Exner DV, Dries DL, Domanski MJ, Cohn JN.
    N Engl J Med; 2001 May 03; 344(18):1351-7. PubMed ID: 11333991
    [Abstract] [Full Text] [Related]

  • 15. Tolerability of carvedilol and ACE-Inhibition in mild heart failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN).
    Komajda M, Lutiger B, Madeira H, Thygesen K, Bobbio M, Hildebrandt P, Jaarsma W, Riegger G, Rydén L, Scherhag A, Soler-Soler J, Remme WJ, CARMEN investigators and co-ordinators.
    Eur J Heart Fail; 2004 Jun 03; 6(4):467-75. PubMed ID: 15182773
    [Abstract] [Full Text] [Related]

  • 16. Adjunctive sympathoplegic therapy to ACE inhibition in Blacks with congestive heart failure: a comparison of alpha-1 with beta-1 blockade on exercise tolerance and cardiac sympathovagal reflex activity.
    Ajayi AA, Sofowora GG, Adigun AQ, Asiyanbola B.
    Ethn Dis; 2003 Jun 03; 13(1):71-9. PubMed ID: 12723015
    [Abstract] [Full Text] [Related]

  • 17. The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction.
    Dries DL, Exner DV, Domanski MJ, Greenberg B, Stevenson LW.
    J Am Coll Cardiol; 2000 Mar 01; 35(3):681-9. PubMed ID: 10716471
    [Abstract] [Full Text] [Related]

  • 18. Enalapril prevents clinical proteinuria in diabetic patients with low ejection fraction.
    Capes SE, Gerstein HC, Negassa A, Yusuf S.
    Diabetes Care; 2000 Mar 01; 23(3):377-80. PubMed ID: 10868869
    [Abstract] [Full Text] [Related]

  • 19. Similar clinical benefits from below-target and target dose enalapril in patients with heart failure in the SOLVD Treatment trial.
    Lam PH, Dooley DJ, Fonarow GC, Butler J, Bhatt DL, Filippatos GS, Deedwania P, Forman DE, White M, Fletcher RD, Arundel C, Blackman MR, Adamopoulos C, Kanonidis IE, Aban IB, Patel K, Aronow WS, Allman RM, Anker SD, Pitt B, Ahmed A.
    Eur J Heart Fail; 2018 Feb 01; 20(2):359-369. PubMed ID: 28980368
    [Abstract] [Full Text] [Related]

  • 20. Impact of Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptors Blockers on Mortality in Acute Heart Failure Patients with Left Ventricular Systolic Dysfunction in the Middle East: Observations from the Gulf Acute Heart Failure Registry (Gulf CARE).
    Al-Zakwani I, Sulaiman K, Al-Lawati JA, Alsheikh-Ali AA, Panduranga P, Al-Habib KF, Al Suwaidi J, Al-Mahmeed W, Al-Faleh H, Elasfar A, Al-Motarreb A, Ridha M, Bulbanat B, Al-Jarallah M, Bazargani N, Asaad N, Amin H.
    Curr Vasc Pharmacol; 2018 Feb 01; 16(6):596-602. PubMed ID: 28820057
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.